Literature DB >> 15149664

Exploring the possible binding sites at the interface of triosephosphate isomerase dimer as a potential target for anti-tripanosomal drug design.

L Michel Espinoza-Fonseca1, José G Trujillo-Ferrara.   

Abstract

To explore the possible binding sites at the interface of tripanosomal triosephosphate isomerase, fully flexible benzothiazoles were docked onto the dimer interface. Docking studies revealed that the most favorable interactions occur in the aromatic clusters of the dimeric form. Hence is purposed that the dimer disruption is not via Cys 15, as presented in last studies, but it could be carried out through the unstabilization of pi-pi interactions of two aromatic clusters present in the interface. These studies enable a novel alternative for rational structure-based anti-tripanosomal drug design.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149664     DOI: 10.1016/j.bmcl.2004.04.013

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  How an Inhibitor Bound to Subunit Interface Alters Triosephosphate Isomerase Dynamics.

Authors:  Zeynep Kurkcuoglu; Doga Findik; Ebru Demet Akten; Pemra Doruker
Journal:  Biophys J       Date:  2015-07-16       Impact factor: 4.033

2.  Species-Specific Inactivation of Triosephosphate Isomerase from Trypanosoma brucei: Kinetic and Molecular Dynamics Studies.

Authors:  Alejandra Vázquez-Raygoza; Lucia Cano-González; Israel Velázquez-Martínez; Pedro Josué Trejo-Soto; Rafael Castillo; Alicia Hernández-Campos; Francisco Hernández-Luis; Jesús Oria-Hernández; Adriana Castillo-Villanueva; Claudia Avitia-Domínguez; Erick Sierra-Campos; Mónica Valdez-Solana; Alfredo Téllez-Valencia
Journal:  Molecules       Date:  2017-11-24       Impact factor: 4.411

3.  Crystal structures of Triosephosphate Isomerases from Taenia solium and Schistosoma mansoni provide insights for vaccine rationale and drug design against helminth parasites.

Authors:  Pedro Jimenez-Sandoval; Eduardo Castro-Torres; Rogelio González-González; Corina Díaz-Quezada; Misraim Gurrola; Laura D Camacho-Manriquez; Lucia Leyva-Navarro; Luis G Brieba
Journal:  PLoS Negl Trop Dis       Date:  2020-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.